Quick Answer: Which Fertility Supplements Are Worth Considering?
There is no single best supplement stack for everyone trying to conceive. The useful distinction is between meeting nutritional needs, treating a diagnosed deficiency and trying an add-on intended to improve a fertility-treatment outcome. Those decisions require different evidence.
Folic acid has an established role before pregnancy in preventing neural tube defects. CoQ10 and other add-ons have more limited, population-specific fertility evidence. A change in insulin, an egg or embryo marker, or a semen measure does not automatically mean a higher live-birth rate. Use the comparison below to identify the relevant question before adding a product.
Fertility Supplements at a Glance
| Question | Evidence to consider | What it does not establish | Next guide |
|---|---|---|---|
| Preparing for pregnancy | Folic-acid guidance for people who could become pregnant | A general treatment for infertility or proof that methylfolate is better for conception | Prenatal ingredient comparisons |
| Low iron or another suspected deficiency | Assess the actual deficiency, cause and existing diet/supplements | A universal fertility ferritin target or a need for everyone to add iron | Iron evidence and testing questions |
| Egg/embryo outcomes during ART | CoQ10 review: clinical-pregnancy signal, uncertain live birth | A proven brand, form, age-based dose or benefit for every person trying naturally | Understanding egg-quality research |
| PCOS-related infertility | Guideline and individual treatment context | A proven inositol ratio or routine multi-supplement protocol | PCOS supplement evidence |
| Male infertility | AUA/ASRM: uncertain clinical usefulness of supplements | That a semen-marker improvement guarantees pregnancy or live birth | Male fertility evidence |
| Preparing for IVF | Current ovarian-stimulation guidance | That a general website can set retrieval/transfer stop dates | IVF supplement questions |
Start With the Outcome the Research Measured
Research can ask whether a nutrient changes blood levels, insulin resistance, ovulation, the number of retrieved eggs, embryo grading, semen parameters, clinical pregnancy or live birth. Those outcomes describe different steps. A promising result at one step is not proof of benefit at every later step.
Also check who was studied. Findings in people with a diagnosis, deficiency or specific IVF protocol may not apply to someone without that condition. A trial of a combined product does not isolate every ingredient, and a blood-absorption comparison cannot establish which product results in more births.
Folate and Folic Acid Before Pregnancy
CDC advises 400 mcg of folic acid daily for people who could become pregnant, including those with common MTHFR variants. These variants are not a reason to avoid folic acid. This public-health recommendation concerns prevention of neural tube defects; it should not be relabeled as proof of better egg quality. Read the CDC guidance.
Check the amount on your prenatal and discuss circumstances that may require different care. Do not infer a higher dose from a common variant alone, or assume a methylfolate label proves a safer or more effective fertility product. The preconception vitamin guide addresses related label questions.
CoQ10: Promising Findings With Important Limits
A review of five randomized trials involving 449 women receiving assisted reproduction found higher clinical pregnancy with CoQ10 but no statistically significant difference in live birth or miscarriage. This is a reason to examine the evidence with a treatment team, rather than declare a fertility-outcome winner. Florou et al., 2020.
The often-cited Xu trial randomized 186 women under 35 with reduced ovarian reserve; 169 were evaluated. Some ovarian and embryo outcomes improved, while clinical pregnancy and live-birth differences were not statistically significant. It does not establish a dosing protocol for every older reader. Xu et al., 2018.
Compare CoQ10 product labels, amounts studied in CoQ10 research and ubiquinol versus ubiquinone evidence as separate questions. Higher blood absorption, age or a form name alone does not prove better reproductive outcomes.
Vitamin D, Magnesium and Zinc
These nutrients have normal physiological roles. That does not mean most readers are deficient or that an extra supplement is a necessary fertility treatment. Assess diet, an existing prenatal, health conditions and any indication for testing or supplementation.
The vitamin-D association review cited in fertility discussions pooled cohort studies, not supplementation trials. Its findings cannot establish that taking vitamin D causes a pregnancy benefit or that everyone should target 40–60 ng/mL. Chu et al., 2018. NIH guidance discusses nutritional assessment and excess risk; this overview supplies no universal blood target or loading regimen.
For magnesium, a PCOS review found inconsistent experimental results for insulin resistance, rather than an established fertility benefit. Hamilton et al., 2019. Our magnesium comparison separates elemental amounts and serving formats from fertility claims.
For zinc, a large trial in 2,370 couples seeking infertility treatment found no significant live-birth or most semen-quality benefit from the combined folic-acid/zinc intervention. It does not answer every deficiency-treatment question, but it argues against presenting that combination as universally effective. Schisterman et al., 2020. See the zinc label comparison.
Omega-3s: Association and Treatment Are Different
A prospective cohort associated self-reported omega-3 supplement use with a higher probability of conception. Supplement users also differed from nonusers in other ways; the authors noted the observational design. The result does not establish a dose or prove that the supplement caused the difference. Stanhiser et al., 2022.
A broader review also reported favorable findings across differing diet/supplement studies and populations. Such pooling does not turn all fish oils, algae products and amounts into equivalent treatments. Trop-Steinberg et al., 2024. Read the omega-3 evidence guide with that distinction in mind.
PCOS and Myo-Inositol
Inositol research includes signals for some metabolic and reproductive measures, but current international guidance treats infertility use as experimental. The guideline-informing review describes limited, inconclusive evidence; newer syntheses include both favorable and uncertain results. Fitz et al., 2024; current guideline portal.
The myo-inositol guide compares study amounts, formulations and newer findings. The PCOS guide addresses the wider treatment context, while the PCOS diet guide focuses on sustainable food choices. Neither a 40:1 label nor a change in insulin establishes an individualized fertility protocol.
Iron, Vitamin C, NAC and Probiotics
Iron treatment should follow an assessment of deficiency and its cause. The often-quoted iron study was observational, and the later clinic study concerned iron-deficient patients receiving infusions. Neither establishes a universal ferritin target or oral fertility dose. The iron guide separates these studies and nutritional needs.
Small vitamin-C studies include uncontrolled designs, associations and mixtures. They do not establish that most adults trying to conceive benefit from an extra 500–1,000 mg each day. See the vitamin-C evidence guide for study-specific limits.
NAC research includes hormone and ovulation-related measures in selected groups. A study amount or mechanistic antioxidant role is not proof of a standard multi-product fertility regimen. The NAC guide covers the topic; any claim about pregnancy or live birth needs its own direct support.
For probiotics, newer reviews report encouraging results in some infertility settings but important limits in certainty, product, route and outcomes. A microbiome association does not prove that an arbitrary retail strain blend improves implantation. The probiotic guide should be read with those formulation-specific questions. 2026 systematic review.
Selenium, DHEA, Melatonin and Herbal Products
A selenium-plus-vitamin-E report assessed a combined intervention and before/after semen measures. It does not identify a universal selenium-only fertility dose or justify a stack for every man. Moslemi and Tavanbakhsh, 2011. The broader Cochrane male-antioxidant review rates key evidence low or very low certainty.
DHEA is a hormone precursor. Current ESHRE ovarian-stimulation guidance does not recommend it for low responders; selected positive studies do not make it a routine pre-IVF protocol. Guideline. The DHEA review describes the evidence and risks without a self-directed dose or stop schedule.
Sleep-related or antioxidant mechanisms do not establish melatonin as a routine fertility add-on. NCCIH notes limited pregnancy/breastfeeding safety research. Melatonin safety information. Herbal products also require ingredient-specific evidence and interaction review; “natural” does not establish safety.
Royal jelly has preliminary human evidence involving different preparations and routes, plus important allergy concerns. Read the royal-jelly evidence review rather than extrapolating from bee biology or an isolated case report. For endometriosis, separate symptom outcomes from fertility outcomes in the condition-specific guide.
How to Review a Fertility Supplement Stack
A stack combines uncertainties as well as ingredients. Even if individual products were studied, that does not prove the exact combination is more effective or free of interactions. Food intake, a prenatal, medicines, kidney or liver disease, pregnancy and treatment procedures can change the assessment.
- List every product, serving unit and nutrient amount, including a prenatal and overlapping ingredients.
- Identify the reason for each addition: a nutritional need, diagnosed deficiency or proposed treatment add-on.
- Ask whether the supporting trial tested that exact combination and a meaningful outcome.
- Have the full list reviewed by the treating clinician or pharmacist. Procedure stop/restart instructions should come from that team.
- Agree what would be reassessed and when; a study duration is not a guaranteed time to benefit.
Comparing Product Labels Without Inventing a Winner
Read elemental nutrient amounts, amounts per serving versus per capsule, complete ingredients and the exact product variant. A quality certificate can address its stated testing scope; it cannot establish a pregnancy benefit. Manufacturer marketing and a reviewer’s explanation are not substitutes for a clinical comparison.
The existing magnesium, zinc and CoQ10 comparisons help identify label differences. A product with a higher milligram amount is not automatically more appropriate. Product-specific testing or first-hand use should only be claimed when it was actually performed.
See how to read a magnesium serving correctly using the annotated label and elemental-amount worksheet.
Before relying on a quality mark, read how to verify supplement certifications and match the issuer, formula and scope.
Frequently Asked Questions
What is the best supplement for fertility?
The answer depends on the purpose. Folic-acid guidance before pregnancy, treatment of a diagnosed deficiency and an unproven fertility add-on are different decisions. No all-purpose stack is established by the evidence summarized here.
How long do fertility supplements take to work?
Trial preparation periods and reproductive biology do not establish a reliable individual response time. Discuss the intended outcome and a reassessment plan rather than assuming three months will produce a benefit.
Can I take these with a prenatal or during pregnancy?
Check the complete ingredients and total amounts with your care team. Pregnancy safety and procedure instructions cannot be inferred from a preconception study or a blanket compatibility statement.
Are the recommendations the same for men and women?
No universal sex-based regimen is established here. Deficiency treatment, male-factor evaluation and particular assisted-reproduction settings involve different questions. Women’s fertility overview and male fertility evidence provide related context.
Does correcting a low nutrient level prove supplements improve fertility?
Correcting a documented deficiency and improving fertility outcomes are separate questions. A study of deficiency treatment cannot establish that adding more benefits someone already getting enough.
Related Guides
These articles address separate questions; linking them does not establish that their products should be combined.
Research Sources
These references identify the studies discussed above. Their presence does not mean every study demonstrates a fertility benefit or applies to every reader.
- Florou P, Anagnostis P, Theocharis P et al. Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. Journal of assisted reproduction and genetics. 2020.
- Xu Y, Nisenblat V, Lu C et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reproductive biology and endocrinology : RB&E. 2018.
- Chu J, Gallos I, Tobias A et al. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Human reproduction (Oxford, England). 2018.
- Hamilton KP, Zelig R, Parker AR et al. Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome. Current developments in nutrition. 2019.
- Schisterman EF, Sjaarda LA, Clemons T et al. Effect of Folic Acid and Zinc Supplementation in Men on Semen Quality and Live Birth Among Couples Undergoing Infertility Treatment: A Randomized Clinical Trial. JAMA. 2020.
- Stanhiser J, Jukic AMZ, McConnaughey DR et al. Omega-3 fatty acid supplementation and fecundability. Human reproduction (Oxford, England). 2022.
- Trop-Steinberg S, Gal M, Azar Y et al. Effect of omega-3 supplements or diets on fertility in women: A meta-analysis. Heliyon. 2024.
- Fitz V, Graca S, Mahalingaiah S et al. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. The Journal of clinical endocrinology and metabolism. 2024.
- Moradi M, Grieger JA, Tong Y et al. Oral and Vaginal Probiotics and Pregnancy Outcomes in Women With Infertility: A Systematic Review and Meta-analysis. Obstetrics and gynecology. 2026.
- Moslemi MK, Tavanbakhsh S. Selenium-vitamin E supplementation in infertile men: effects on semen parameters and pregnancy rate. International journal of general medicine. 2011.
- de Ligny W, Smits RM, Mackenzie-Proctor R et al. Antioxidants for male subfertility. The Cochrane database of systematic reviews. 2022.
Research and guidance checked November 17, 2026. This is an editorial source review, not an individual clinical assessment or a guarantee of treatment benefit.
Medical information: Educational content does not replace diagnosis or treatment by a qualified healthcare professional. Review medicines, pregnancy and supplement decisions with your care team.